Form 4: Inari Medical Director William Hoffman Sells Shares Under 10b5-1 Trading Plan

Director William Hoffman of Inari Medical, Inc. executed sales of common stock on March 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• William Hoffman, a director at Inari Medical, Inc., sold shares of common stock on March 18, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 14, 2023.
• A total of 27,492 shares were sold at a weighted average price of $40.98, and 12,508 shares were sold at a weighted average price of $41.45.
• Following these transactions, Hoffman directly owns 1,003,296 shares of Inari Medical, Inc.
• The transactions were reported on a Form 4 filing with the SEC.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock sales by a company director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

This is a routine disclosure of insider trading activity. Insiders often use 10b5-1 plans to avoid accusations of trading on non-public information.

Stakeholder Impact

• The stock sale by a director could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this.

Key Dates